Scarica l'app Stockscreener
0.8198
1.82%
-0.0152
Dopo l'orario di chiusura:
.83
0.0102
+1.24%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché MXCT Giù?
Forum
Previsione
Precedente Chiudi:
$0.835
Aprire:
$0.839
Volume 24 ore:
1.05M
Relative Volume:
0.99
Capitalizzazione di mercato:
$87.45M
Reddito:
$34.42M
Utile/perdita netta:
$-45.63M
Rapporto P/E:
-1.9074
EPS:
-0.4298
Flusso di cassa netto:
$-41.23M
1 W Prestazione:
+4.78%
1M Prestazione:
+13.92%
6M Prestazione:
-43.46%
1 anno Prestazione:
-73.21%
Intervallo 1D:
$0.8103
$0.8731
Intervallo di 1 settimana:
$0.7403
$0.8731
Portata 52W:
$0.6434
$3.33
Maxcyte Inc Stock (MXCT) Company Profile
Nome
Maxcyte Inc
Settore
Industria
Telefono
301-517-5556
Indirizzo
9713 KEY WEST AVENUE,, ROCKVILLE
Compare MXCT vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MXCT
Maxcyte Inc
|
0.8198 | 87.45M | 34.42M | -45.63M | -41.23M | -0.4298 |
|
ABT
Abbott Laboratories
|
108.03 | 187.72B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
336.77 | 128.88B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
87.14 | 111.88B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.13 | 102.58B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
81.81 | 47.52B | 6.07B | 1.06B | 1.34B | 1.8063 |
Maxcyte Inc Stock (MXCT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-08-11 | Downgrade | BTIG Research | Buy → Neutral |
| 2025-08-07 | Downgrade | William Blair | Outperform → Mkt Perform |
| 2025-07-22 | Iniziato | Stephens | Overweight |
| 2023-11-29 | Iniziato | Craig Hallum | Buy |
| 2021-10-15 | Ripresa | Cowen | Outperform |
| 2021-08-24 | Iniziato | BTIG Research | Buy |
| 2021-08-24 | Iniziato | Cowen | Outperform |
| 2021-08-24 | Iniziato | Stephens | Overweight |
| 2021-08-24 | Iniziato | Stifel | Buy |
| 2021-08-24 | Iniziato | Wedbush | Outperform |
| 2021-08-24 | Iniziato | William Blair | Outperform |
Mostra tutto
Maxcyte Inc Borsa (MXCT) Ultime notizie
Risk Check: Should I average down on MaxCyte Inc stock2026 WrapUp & Daily Profit Focused Screening - baoquankhu1.vn
Insider Sell: Will MaxCyte Inc outperform tech stocksInflation Watch & High Conviction Buy Zone Alerts - baoquankhu1.vn
MaxCyte unveils new 96-well electroporation platform to accelerate discovery - Select Science
MaxCyte (NASDAQ:MXCT) Stock Rating Lowered by Wall Street Zen - MarketBeat
Why MaxCyte Inc. stock attracts high net worth investorsBuy Signal & Intraday High Probability Setup Alerts - Naître et grandir
Options Flow: Can MaxCyte Inc sustain its profitabilityJuly 2025 Fed Impact & Safe Capital Growth Stock Tips - baoquankhu1.vn
MaxCyte, Inc. (NASDAQ:MXCT) Short Interest Update - MarketBeat
Free cash flow per share of MaxCyte, Inc. – FWB:MYE0 - TradingView
MaxCyte, Inc. (NASDAQ:MXCT) Receives Average Rating of "Hold" from Analysts - MarketBeat
MaxCyte, Inc.Common Stock (NQ: MXCT - The Chronicle-Journal
MaxCyte unveils ExPERT DTx, a 96-well electroporation platform to accelerate discovery - marketscreener.com
MaxCyte (MXCT) Launches ExPERT DTx Platform to Accelerate High-Throughput Drug Discovery - Finviz
Insider Buy: Is MaxCyte Inc trading at a discountJuly 2025 Analyst Calls & Fast Entry and Exit Trade Plans - baoquankhu1.vn
MaxCyte unveils ExPERT DTx™, a 96-well electroporation platform to accelerate discovery - The Manila Times
New MaxCyte lab device runs 96 cell samples in a three-minute cycle - Stock Titan
MXCT | MaxCyte, Inc. Common Stock FinancialsIncome Statement - Quiver Quantitative
MaxCyte to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026 - The Manila Times
MaxCyte, Inc. to Release Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026 - Quiver Quantitative
MaxCyte schedules March 24 call on 2025 results for 4:30 p.m. ET - Stock Titan
MXCT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Market Leaders: What is BEDUs book value per shareWeekly Volume Report & Long-Term Growth Stock Strategies - baoquankhu1.vn
Take Profit: Is MaxCyte Inc a momentum stockJuly 2025 PostEarnings & Capital Protection Trading Alerts - baoquankhu1.vn
What are MaxCyte Inc.’s recent SEC filings showingMarket Activity Recap & Daily Profit Focused Stock Screening - mfd.ru
Dividend Watch: Is MaxCyte Inc forming a breakout patternWeekly Trade Analysis & Smart Allocation Stock Tips - baoquankhu1.vn
Day Trade: Will MaxCyte Inc benefit from rising consumer demand2025 Trading Volume Trends & Accurate Buy Signal Notifications - baoquankhu1.vn
Cadian Capital discloses 3.5% MaxCyte (MXCT) stake in latest 13G/A - Stock Titan
MaxCyte, Inc. (NASDAQ:MXCT) Short Interest Up 55.1% in January - MarketBeat
Is MaxCyte Inc. being accumulated by smart money2025 Institutional Moves & Daily Market Momentum Tracking - mfd.ru
Will MaxCyte Inc. stock outperform Nasdaq indexJuly 2025 Final Week & Consistent Profit Trade Alerts - mfd.ru
Is MaxCyte Inc. stock gaining market shareTreasury Yields & Short-Term High Return Ideas - mfd.ru
Capricorn Fund Managers Ltd Acquires 8,200,000 Shares in MaxCyte Inc - GuruFocus
Is MaxCyte Inc. stock a value trapJuly 2025 Review & Real-Time Stock Movement Alerts - mfd.ru
Will MaxCyte Inc. benefit from rising consumer demandBond Market & Community Trade Idea Sharing - mfd.ru
Brokerages Set MaxCyte, Inc. (NASDAQ:MXCT) PT at $7.00 - Defense World
MaxCyte (NASDAQ:MXCT) Upgraded to Hold at Wall Street Zen - MarketBeat
Capricorn Fund takes 7.7% stake in MaxCyte (NASDAQ: MXCT) - Stock Titan
MaxCyte (NASDAQ:MXCT) Stock Price Down 4.2%Here's Why - MarketBeat
Sentiment Recap: Can ATGL grow without dilutionQuarterly Growth Report & Technical Entry and Exit Tips - baoquankhu1.vn
MaxCyte team building boosts morale at sales meeting - Traders Union
Hedge Fund Moves: Will MaxCyte Inc outperform small cap indexes2025 Earnings Surprises & Reliable Intraday Trade Plans - baoquankhu1.vn
Aug Action: Is MaxCyte Inc showing insider buyingDip Buying & Reliable Price Breakout Signals - baoquankhu1.vn
IPO Launch: Is MaxCyte Inc showing insider buying2025 Historical Comparison & High Conviction Buy Zone Alerts - baoquankhu1.vn
Can MaxCyte Inc. disrupt its industryWeekly Loss Report & Daily Profit Maximizing Tips - mfd.ru
Hedge Fund Bets: Is Algoma Steel Group Inc benefiting from interest rate changesMarket Performance Recap & High Return Stock Watch Alerts - baoquankhu1.vn
Rally Mode: Is MaxCyte Inc showing insider buyingTrend Reversal & Safe Entry Zone Tips - baoquankhu1.vn
Dip Buying: Is INEO forming a breakout patternJuly 2025 Recap & Consistent Return Strategy Ideas - baoquankhu1.vn
Portfolio Shifts: What is the next catalyst for MaxCyte IncFed Meeting & Breakout Confirmation Alerts - baoquankhu1.vn
Investor Mood: How interest rate cuts could boost MaxCyte Inc stockQuarterly Profit Report & Community Verified Trade Signals - Bộ Nội Vụ
MaxCyte to join the 2026 G-Rex Grant Tour in Houston - Traders Union
Published on: 2026-01-14 11:01:42 - baoquankhu1.vn
Day Trade: Is MaxCyte Inc stock affected by interest rate hikesOil Prices & Safe Entry Momentum Stock Tips - Bộ Nội Vụ
Maxcyte Inc Azioni (MXCT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.66%
1.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):